Glioblastoma remains a highly challenging malignancy with a pronounced tendency for recurrence. The hypoxic microenvironment ...

A team of researchers from Brown University Health and Brown University has uncovered an important clue in the fight against ...

The multi-kinase inhibitor regorafenib did not improve overall survival (OS) compared with standard treatment for patients with newly diagnosed unmethylated or recurrent glioblast ...

Glioblastoma, the most aggressive malignant brain tumor in adults, is not an isolated lesion, but a disease that destabilizes ...

A new glioblastoma treatment showed tumour elimination and durable protection in a preclinical model. Discover what this ...

Combining microchip engineering techniques with cutting-edge gene profiling, scientists at Columbia University have developed ...

A new grant from the American Cancer Society (ACS) will fund research into a new strategy for targeting glioblastoma at MUSC ...

Add Yahoo as a preferred source to see more of our stories on Google. Before her death earlier this month, Madeleine Sophie Wickham, known by her pen name Sophie Kinsella, was known for creating ...

A study appearing in Nature investigated the role of astrocytes, an abundant cell type in the brain, in regulating an immune response against glioblastoma (GBM)—a highly aggressive brain cancer.

Glioblastoma (GBM), an aggressive form of cancer that grows in the brain or spinal cord, occurs at an incidence rate of about 3/100,000 persons in the United States. Effective treatments remain ...

Researchers at the Perelman School of Medicine at the University of Pennsylvania have for the first time used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to ...